Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02967055 · ClinicalTrials.gov registry record
The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 9
- Enrollment target
NCT02967055: Completed study, sponsored by University of Colorado, Denver.
NCT02967055 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02967055 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.
Primary Outcome
ENG levels will be measured prior to initiation of isotretinoin therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-06-30 |
What the finished NCT02967055 record still lists
NCT02967055 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02967055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02967055 about?
NCT02967055 is a clinical study titled "The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant". This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.
What is the current status of trial NCT02967055?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2017-02-15. Estimated completion is 2019-06-30.
Who is sponsoring clinical trial NCT02967055?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI